Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
18 November 2024 - preview of changes for December 2024
Pharmaceutical |
Change |
---|---|
Amoxicillin with clavulanic acid (Augmentin) grans for oral liq 25 mg with clavulanic acid 6.25 mg per ml, 100 ml |
addition of PSS |
Beta-hCG low sensitivity urine test kit (CheckToP) midstream |
new listing (p’code 2625946) |
Betamethasone valerate (Betnovate) lotn 0.1%, 50 ml |
price increase and addition of PSS |
Cisplatin (Cisplatin Accord) inj 1 mg per ml, 50 ml vial |
new listing (p’code 2694344) |
Compound electrolytes (Plasma-Lyte 148) inj sodium 140 mmol/l, potassium 5 mmol/l, magnesium 1.5 mmol/l, chloride 98 mmol/l, acetate 27 mmol/l, gluconate 23 mmol/l, 500 ml and 1,000 ml bag |
price increase |
Compound electrolytes with glucose [dextrose] (Plasma-Lyte 148 & 5% Glucose) inj sodium 140 mmol/l, 5 mmol/l potassium, 1.5 mmol/l magnesium, 98 mmol/l chloride, 27 mmol/l acetate and 23 mmol/l gluconate, glucose 23 mmol/l (5%), 1,000 ml bag |
price increase |
Compound sodium lactate [hartmann’s |
price increase |
Dexamfetamine sulfate (Noumed Dexamfetamine) tab 5 mg |
amended restriction criteria |
Efavirenz (Stocrin) tab 200 mg and 600 mg |
delisted 1 December 2024 |
Empagliflozin (Jardiance) tab 10 mg and 25 mg |
removal of note |
Empagliflozin with metformin hydrochloride (Jardiamet) tab 5 mg with 500 mg and 1,000 mg metformin hydrochloride and tab 12.5 mg with 500 mg and 1,000 mg metformin hydrochloride |
removal of note |
Everolimus (Afinitor) tab 5 mg and 10 mg |
amended restriction criteria |
Fentanyl (Boucher and Muir) inj 50 mcg per ml, 2 ml ampoule |
price increase and addition of PSS |
Fentanyl (Boucher and Muir) inj 50 mcg per ml, 10 ml ampoule |
addition of PSS |
Flecainide acetate (Almarytm) inj 10 mg per ml, 15 ml ampoule |
new listing (p’code 2694956) |
Gentamicin sulphate (Cidomycin P/Free) inj 40 mg per ml, 2 ml ampoule |
new listing (p’code 2695588) |
Glucose [dextrose]
|
price increase |
Glucose with potassium chloride and sodium
|
price increase |
Glucose with sodium chloride (Baxter) inj glucose 2.5% with sodium chloride 0.45%, 500 ml bag |
new listing (p’code 2541769) |
Glucose with sodium chloride (Baxter)
|
price increase |
Heparin sodium (Wockhardt PSF) inj 1,000 iu per ml, 5 ml ampoule |
new listing (p’code 2694948) |
High protein oral feed 2.4 kcal/ml (e.g. Fortisip Compact Protein) liquid 14.6 g protein, 25.3 g carbohydrate and 9.6 g fat per 100 ml, 125 ml bottle |
delisting delayed until 1 March 2025 |
Hydroxychloroquine sulphate tab 200 mg |
amended chemical name and restrictions Brand change
|
Ipratropium bromide (Ipratropium IVAX) nebuliser soln 250 mcg per ml, 2 ml ampoule |
to be delisted 1 February 2025 |
Ipratropium bromide (Pharmascience) nebuliser soln 250 mcg per ml, 2 ml ampoule |
to be delisted 1 May 2025 |
Isoniazid tab 100 mg |
Brand change
|
Lenvatinib (Lenvima) cap 4 mg and 10 mg |
new listing
|
Lisdexamfetamine dimesilate (Vyvanse) cap 30 mg, 50 mg and 70 mg |
new listing
|
Mannitol (Baxter) inj 10%, 1,000 ml bag and inj 20%, 500 ml bag |
price increase |
Methylphenidate hydrochloride
|
amended restriction criteria |
Methylthioninium chloride [methylene blue] (Proveblue) inj 5 mg per ml, 10 ml ampoule |
price increase |
Modafinil tab 100 mg |
amended restriction criteria Brand change
|
Norethisterone (Noriday) tab 350 mcg |
new listing (p’code 2695618) |
Octreotide (Omega) inj 50 mcg per ml, 1 ml vial and inj 500 mcg per ml, 1 ml vial |
new listing
|
Pazopanib tab 200 mg and 400 mg |
Brand change Pazopanib Teva – new listing and addition of PSS
Votrient to be delisted 1 May 2025 |
Potassium chloride with sodium chloride
|
price increase |
Ringer’s solution (Baxter) inj sodium 147 mol/l with potassium 4 mmol/l, calcium 2.2 mmol/l, chloride 156 mmol/l, 1,000 ml bag |
new listing (p’code 2541750) |
Salbutamol (Ventolin) oral liq 400 mcg per ml, 150 ml |
price increase and addition of PSS |
Salbutamol with ipratropium bromide (Duolin Cipla) nebuliser soln 2.5 mg with ipratropium bromide 0.5 mg per 2.5 ml ampoule |
to be delisted 1 April 2025 |
SGLT2 Inhibitors |
amended restriction criteria |
Sodium chloride (Baxter)
|
price increase |
Sodium chloride (Baxter Sodium Chloride 0.9%) irrigation soln 0.9%, 1,000 ml bottle |
price increase |
Water (Baxter) inj, 1,000 ml bag |
price increase |
Water (Baxter Water for Irrigation) irrigation soln, 1,000 ml bottle |
price increase |